Bioengineers invent a way to speed up drug discovery

June 19, 2014

Think of the human body as an intricate machine whose working parts are proteins: molecules that change shape to enable our organs and tissues to perform tasks such as breathing or eating or thinking.

Of the millions of proteins, 500 in the kinase family are particularly important to drug discovery. Kinases are messengers: They deliver signals that regulate and orchestrate the actions of other proteins. Proper kinase activity maintains health. Irregular activity is linked to cancer and other diseases. For this reason many drugs seek either to boost or suppress kinase activity.

Now Stanford bioengineers have invented a way to observe and report on the behavior of these signaling proteins as they go about their crucial work inside living cells.

"We've been able to observe multiple kinases functioning in living cells, which is something no one else has ever seen," said Markus Covert, an assistant professor of bioengineering at Stanford and lead author of a paper published today (June 19th) in the journal Cell.

"Cancers can occur when a kinase inappropriately tells a cell to 'grow, grow, grow'," Covert noted. "The reverse can also be true, if a cell reaches what should be the end of its normal life-span but the kinase never says 'die, die, die'."

Using the new technique researchers could observe and compare kinase activity in healthy versus diseased cells – then introduce an experimental drug to see how the proposed remedy affects the living cell.

Prior to this, researchers would have had to pulverize a cell sample, extract the relevant kinase and measure its levels. If they designed a drug to treat the condition, they would have to administer the experimental remedy to a different cell culture, then pulverize this sample and sift out the data on kinase activity.

The video will load shortly

The circle inside each cell is its nucleus. As this video begins the circles are bright, which reveals the presence of inactive kinase protein decoys. After the Stanford bioengineers stimulated the cells to activate the kinases, the nuclear circles darkened again. Kinase proteins regulate health and help cause disease. So creating a way to track these light and dark areas allows researchers to see whether a kinase is active or inactive when a cell is healthy or diseased. This new technique could speed drug discovery. Credit: Sergi Regot, Covert Lab

The new Stanford technique enables researchers to read the activities of multiple in living cells, and if they administer an experimental drug, to observe any changes that result in that same cell sample

Covert believes this process will speed the development of new drugs aimed at cancers and other conditions linked to kinase irregularities. More than two dozen such drugs are on the market or in development today, from companies including Genentech, Amgen, Novartis, Roche and Takeda (see list).

Creating a homing beacon

Sergi Regot, a postdoctoral scholar in Covert's lab, spent more than a year developing and refining the process that he outlined as the first author of the Cell paper.

It all begins with a conceptual understanding of how kinase messenger proteins transmit signals.

Protein signaling is a complex cascade of physical events inside a cell. The protein itself is a long chain of atoms. Different groups of atoms in the chain perform different functions. Some atoms serve as the antenna or receiver that directs the kinase to a specific location. Upon arriving at its destination, the kinase delivers its message, instructing the protein to do something inside the cell.

So the kinase essentially has two parts: One part finds the address inside the cell, and the other part delivers the message.

To track the activity of this signaling system in living cells, Regot came up with the idea of creating a fake destination for the kinase. He called this decoy a Kinase Translocation Reporter (KTR). He tagged the KTRs with a fluorescent protein so he could track their locations inside the cell with special microscopy tools. He added one other crucial element to the KTR: a molecular switch that indicated whether the kinase was active or inactive.

"All of this was easier thought of than accomplished, but in the end we did it," Regot said.

By tracking the intensity of the fluorescent KTRs the bioengineers could tell whether kinase was active or inactive. Kinases are important regulators of cellular activity. The Stanford technique allows researchers to see how specific levels of kinase activity either promote health or trigger disease inside a living cell.

Covert's team spent more than a year working on the technique. So far they have successfully applied the KTR approach to five kinases, and they believe that KTR technology could be extended to other kinases, to make it a widely available and useful tool in drug discovery.

"Imagine you wanted to discover a new drug," Covert said. "You could throw KTRs into a cell culture and observe kinase activity under different conditions."

Related Stories

Millions of people die each year of malaria – a disease transmitted by the Anopheles mosquito. There are major barriers in vaccine development as well as increased resistance to currently available therapies. New biological ...

Researchers at the UNC School of Medicine have devised a new biochemical technique that will allow them and other scientists to delve much deeper than ever before into the specific cellular circuitry that keeps us healthy ...

(Medical Xpress) -- Later-stage cancers thrive by finding detours around roadblocks that cancer drugs put in their path, but a Purdue University biochemist is creating maps that will help drugmakers close more routes and ...

There are thousands of drugs that silence many thousands of cancer-causing genetic abnormalities. Some of these drugs are in use now, but many of these drugs are sitting on shelves or could be used beyond the disease for ...

(Medical Xpress)—The hallmark of cancer is uncontrolled cell growth directed by a cell cycle engine gone into overdrive. The centrepiece of this engine is the enzyme Cdc2 kinase. While Cdc2 kinase is tightly regulated in ...

Recommended for you

(Phys.org)—That there are universal patterns in the naming of colors across languages has long been a topic of discussion in a range of disciplines, including anthropology, cognitive science and linguistics. However, previous ...

It has been 20 years since Dolly the sheep was successfully cloned in Scotland, but cloning mammals remains a challenge. A new study by researchers from the U.S. and France of gene expression in developing clones now shows ...

(Phys.org)—A team of researchers with members from several institutions in China has calculated what they believe is the minimum amount of land preservation needed to sustain wild giant panda populations. In their paper ...

The differences in how male and female fruit flies resist and adapt to oxidative stress may shed new light on how age-related diseases such as Alzheimer's and Parkinson's affect men and women differently.

0 comments

Please sign in to add a comment.
Registration is free, and takes less than a minute.
Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.